205 research outputs found

    The Effect of Rider Level on Equine Mean Heart Rate at the Trot

    Get PDF
    The effect of riders at two different levels of riding ability on the mean heart rates (HR) of school horses at the trot was studied. Five horses were each paired with a beginner (n=4) and an intermediate (n=5) rider, and the mean HR generated by the two riders at the trot were compared for each horse. There was a significant (

    Strategic interaction in the Prisoner's Dilemma: A game-theoretic dimension of conflict research

    Get PDF
    This four-part enquiry treats selected theoretical and empirical developments in the Prisoner's Dilemma. The enquiry is oriented within the sphere of game-theoretic conflict research, and addresses methodological and philosophical problems embedded in the model under consideration. In Part One, relevant taxonomic criteria of the von Neumann- Morgenstern theory of games are reviewed, and controversies associated with both the utility function and game-theoretic rationality are introduced. In Part Two, salient contributions by Rapoport and others to the Prisoner's Dilemma are enlisted to illustrate the model's conceptual richness and problematic wealth. Conflicting principles of choice, divergent concepts of rational choice, and attempted resolutions of the dilemma are evaluated in the static mode. In Part Three, empirical interaction among strategies is examined in the iterated mode. A computer-simulated tournament of competing families of strategies is conducted, as both a complement to and continuation of Axelrod's previous tournaments. Combinatoric sub-tournaments are exhaustively analyzed, and an eliminatory ecological scenario is generated. In Part Four, the performance of the maximization family of strategies is subjected to deeper analysis, which reveals critical strengths and weaknesses latent in its decision-making process. On the whole, an inter-modal continuity obtains, which suggests that the maximization of expected utility, weighted toward probabilistic co-operation, is a relatively effective strategic embodiment of Rapoport's ethic of collective rationality

    IMPACTO DE LA TERAPIA DE INMUNOSUPRESIÓN EN LAS POBLACIONES DE LINFOCITOS T REGULATORIOS EN TRASPLANTE INTESTINAL

    Get PDF
    El trasplante intestinal (TI) se aplica en casos de insuficiencia intestinal y falla de nutrición parenteral total, siendo el rechazo del injerto la complicación más frecuente y con mayor morbimortalidad. Una mejor comprensión de los mecanismos efectores y modulatorios es necesaria para desarrollar nuevas estrategias de control de alorreactividad con una mínima dosis de inmunosupresión (IS) como mantenimiento. Por razones de toxicidad renal asociadas a la terapia inmunosupresora con tacrolimus, se evalúa la posibilidad de su reemplazo por sirolimus. Este último es capaz de bloquear la respuesta efectora sin afectar la generación de células T regulatorias (Tregs), pero aún no ha sido estudiado su impacto en la generación Tregs en el TI. Se ha reportado que la administración de un anticuerpo monoclonal aCD45RC induce tolerancia e inhibición de la respuesta humoral en un modelo de trasplante cardiaco, pero mantiene la respuesta primaria y de memoria. Si bien el TI posee una complejidad mayor, hipotetizamos que la administración de aCD45RC podría inducir tolerancia, controlando el proceso de rechazo. En el presente trabajo nuestro objetivo es analizar la dinámica de las Tregs del injerto en modelos experimentales a fin de determinar su capacidad de controlar el rechazo y definir estrategias inmunosupresoras que maximicen la respuesta regulatoria con una mínima dosis de IS de mantenimiento. En nuestro grupo contamos con un modelo murino de TI alogénico que, por su carácter heterotópico, permite caracterizar en detalle la cinética del rechazo de injerto. Para cumplir el objetivo, contamos con tres grandes grupos de animales: grupo control isogénico, se realiza el TI empleando ratas Wistar como donante y receptor; grupo control de rechazo, se realiza el TI entre ratas Sprague como donantes y Wistar como receptoras sin administración de IS; y el grupo con tratamiento, en el cual se realiza el TI alogénico con distintas terapias inmunosupresoras (monoterapia con tacrolimus, terapia combinada tacrolimus + sirolimus, tacrolimus + aCD45RC y tacrolimus + sirolimus + aCD45RC). Se llevarán a cabo scores clínicos, estudios histopatológicos por tinción con hematoxilina-eosina, cuantificación de células apoptóticas por técnica de TUNEL y expresión de genes por qPCR (IL6, CXCL1, IL22, IL-17, IFN, IL13, IDO, entre otros). Asimismo, con el objetivo de estudiar la funcionalidad del injerto se realizarán pruebas de absorción y permeabilidad para glucosa. También se aislará y caracterizará poblaciones de células T intestinales por citometría de flujo, evaluando activación (CD25+) y fenotipo (expresión de CD45RC, CD4, CD8, FOXP3, PD1, PDL1 y CD45RA). Esperamos correlacionar el éxito clínico de las distintas estrategias analizadas comparativamente con la generación de respuesta T regulatoria en el injerto, lo cual permitirá mejorar la comprensión de la relación entre los distintos tipos de inmunosupresión y la generación de respuesta regulatoria

    What’s so bad about scientism?

    Get PDF
    In their attempt to defend philosophy from accusations of uselessness made by prominent scientists, such as Stephen Hawking, some philosophers respond with the charge of ‘scientism.’ This charge makes endorsing a scientistic stance, a mistake by definition. For this reason, it begs the question against these critics of philosophy, or anyone who is inclined to endorse a scientistic stance, and turns the scientism debate into a verbal dispute. In this paper, I propose a different definition of scientism, and thus a new way of looking at the scientism debate. Those philosophers who seek to defend philosophy against accusations of uselessness would do philosophy a much better service, I submit, if they were to engage with the definition of scientism put forth in this paper, rather than simply make it analytic that scientism is a mistake

    Targeting a cancer-specific LYPD3 glycoform for tumor therapy

    Get PDF
    Introduction: One of the most drastic changes in cancer is the altered glycosylation of proteins and lipids, giving rise to truncated O-glycans like the Thomsen Friedenreich (TF) or Thomsen nouvelle (Tn) antigen, which are almost absent on normal cells. Combined protein-carbohydrate epitopes comprising these specific glycans are ideal candidates for potent targeted therapies given their excellent tumor specificity and broad cancer expression.Methods and results: We have generated GT-002, a monoclonal antibody specifically targeting the epithelial glycoprotein LYPD3 only in the presence of a TF glycosylation. It does not cross-react with non-glycosylated LYPD3 or TF on other glycoproteins in ELISA and flow cytometry. GT-002 binds to various tumor cell lines and stains tumor tissues of different cancer indications including squamous cell carcinoma of the head and neck. The remarkable tumor specificity was confirmed in an immunohistochemistry study on a normal human tissue panel including several LYPD3-positive organs, where GT-002 elicited almost completely abolished normal tissue binding. Consequently, we observed markedly reduced binding of GT-002 to normal human tissues compared to Lupartumab, a conventional anti-LYPD3 antibody previously in clinical development as antibody-drug conjugate (BAY1129980). Neuraminidase treatment of healthy tissues, resulting in cleavage of sialic acid residues, re-established binding of GT-002 comparable to Lupartumab, showing that the GT-002 epitope is masked by sialic acid in normal cells.Discussion: We believe that GT-002 is a promising candidate for development of antibody-drug- and radio-conjugates as well as bispecific molecules and chimeric antigen receptor therapeutics and highlights the powerful potential of antibodies against combined protein-carbohydrate epitopes to reduce on-target/off-tumor cytotoxicity
    corecore